Bellerophon Therapeutics, Inc. Business Finance Contracts & Agreements
22 Contracts & Agreements
- Credit Agreements (1 contract)
- Purchase Agreements (4)
- Registration Rights Agreements (2)
- Stock Agreements (5)
- Subscription Agreements (2)
- Underwriting Agreements (3)
- Warrant Agreements (5)
- Subscription Agreement, dated as of March 3, 2023, by and among Bellerophon Therapeutics, Inc. and the purchaser identified on the signature pages thereto (Filed With SEC on March 6, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on March 6, 2023)
- Subscription Agreement by and between Bellerophon Therapeutics, Inc. and Puissance Life Science Opportunities Fund VI, dated May 18, 2020 (Filed With SEC on May 20, 2020)
- Underwriting Agreement by and between Bellerophon Therapeutics, Inc. and Jefferies LLC, dated May 18, 2020 (Filed With SEC on May 20, 2020)
- Form of Securities Purchase Agreement, dated as of March 30, 2020, by and among Bellerophon Therapeutics, Inc. and the Investors (Filed With SEC on March 30, 2020)
- Binding Term Sheet and Agreement for Line of Credit Facility dated December 16, 2019 between the Company and the signatories identified therein (Filed With SEC on December 17, 2019)
- Form of Warrant Amendment, dated June 28, 2019 (Filed With SEC on July 1, 2019)
- Underwriting Agreement, dated January 23, 2019, by and between Bellerophon Therapeutics, Inc. and H.C. Wainwright & Co (Filed With SEC on January 23, 2019)
- Form of Warrant Agreement (Filed With SEC on September 27, 2017)
- Registration Rights Agreement, dated September 26, 2017, among the Registrant and the investors named therein (Filed With SEC on September 27, 2017)
- Securities Purchase Agreement, dated September 26, 2017 , among the Registrant and the investors named therein (Filed With SEC on September 27, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 12, 2017)
- COMMON STOCK PURCHASE WARRANT BELLEROPHON THERAPEUTICS, INC. (Filed With SEC on May 12, 2017)
- FORM OF COMMON STOCK PURCHASEWARRANT BELLEROPHONTHERAPEUTICS, INC. (Filed With SEC on November 21, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 10, 2016)
- COMMON STOCK PURCHASE WARRANT BELLEROPHONTHERAPEUTICS, INC. (Filed With SEC on November 10, 2016)
- BELLEROPHON THERAPEUTICS, INC. Common Stock (par value $0.01 per share) (Filed With SEC on May 27, 2016)
- BELLEROPHON THERAPEUTICS, INC. RESTRICTED STOCK AGREEMENT (Filed With SEC on December 4, 2015)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 3, 2015)
- BELLEROPHON THERAPEUTICS, INC. NONSTATUTORY STOCK OPTION AGREEMENT (Filed With SEC on February 3, 2015)
- BELLEROPHON THERAPEUTICS, INC. (a Delaware corporation) [] Shares of Common Stock FORM OF UNDERWRITING AGREEMENT Dated: [], 2015 (Filed With SEC on February 3, 2015)
- ASSUMED IKARIA HOLDINGS, INC. 2007 STOCK OPTION PLAN (Filed With SEC on January 13, 2015)